Back to Search
BRADY MOCK, M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1841630183IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
2018-00406(NC)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility.
PMID 19654412·Blood·2009
7-preclinical
Dopamine transporter binding in rat striatum: a comparison of [O-methyl-11C]beta-CFT and [N-methyl-11C]beta-CFT.
PMID 19181264·Nucl Med Biol·2009
4-observational
Developmental differences in learning and error processing: evidence from ERPs.
PMID 19497006·Psychophysiology·2009
8-other
Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors.
PMID 18155914·Appl Radiat Isot·2008
8-other
Better or worse than expected? Aging, learning, and the ERN.
PMID 17936313·Neuropsychologia·2008
4-observational
Synthesis and biodistribution of new radiolabeled high-affinity choline transporter inhibitors [11C]hemicholinium-3 and [18F]hemicholinium-3.
PMID 17303422·Bioorg Med Chem Lett·2007
7-preclinical
Partial k-space reconstruction in single-shot diffusion-weighted echo-planar imaging.
PMID 17326165·Magn Reson Med·2007
8-other
Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.
PMID 17116396·Bioorg Med Chem·2007
7-preclinical
Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents.
PMID 16962783·Bioorg Med Chem·2006
7-preclinical
Interferon-alphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Effect on disease control and systemic glucocorticosteroid dose.
PMID 16195656·Respiration·2006
5-case
A physiologic imaging pilot study of breast cancer treated with AZD2171.
PMID 16397053·Clin Cancer Res·2006
7-preclinical
Synthesis and initial PET imaging of new potential dopamine D3 receptor radioligands (E)-4,3,2-[11C]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides.
PMID 16087340·Bioorg Med Chem·2005
7-preclinical
Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
PMID 15982585·Nucl Med Biol·2005
7-preclinical
Dopamine D(2) receptor availability is associated with subjective responses to alcohol.
PMID 15976522·Alcohol Clin Exp Res·2005
4-observational
Facile synthesis and PET imaging of a novel potential heart acetylcholinesterase tracer N-[11C]methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2',2'-diphenylpropionoxymethyl)pyridinium.
PMID 16112863·Bioorg Med Chem Lett·2005
7-preclinical
Purification of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE.
PMID 15803445·Biomed Chromatogr·2005
8-other
[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.
PMID 15142549·Bioorg Med Chem·2004
7-preclinical
The Collaborative Cross, a community resource for the genetic analysis of complex traits.
PMID 15514660·Nat Genet·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2001 VAIL AVE STE 200
CHARLOTTE, NC 28207 - Phone
- (704) 323-2000
Quick Facts
- NPI
- 1841630183
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile